Jennifer M. Yeh

Jennifer M. Yeh, PhD, is an Assistant Professor of Pediatrics at Harvard Medical School and an Associate Scientific Researcher in the Division of General Pediatrics at Boston Children's Hospital. Her research utilizes decision-analytic modeling and cost-effectiveness analysis to evaluate clinical guidelines and health policies, with a primary focus on cancer control spanning prevention to survivorship.

Dr. Yeh's educational background includes:

• B.A. in Biology from University of Colorado at Boulder
• M.S. in Health Policy and Management from Harvard T.H. Chan School of Public Health
• PhD in Health Policy (Decision Sciences concentration) from Harvard University
• NCI-sponsored post-doctoral fellowship at Harvard T.H. Chan School of Public Health and Dana Farber/Harvard Cancer Center

Her research integrates three core domains:

• Methodological innovation in simulation modeling incorporating early-life exposures and long-term outcomes
• Cancer control optimization across gastric cancer prevention and childhood cancer survivorship
• Health policy evaluation focusing on screening guidelines and surveillance programs

She has developed novel approaches to quantify treatment-related risks for secondary cancers, cardiac events, and late effects in survivors.

Her recent publications demonstrate three key interdisciplinary themes: longitudinal analysis of cancer survivorship outcomes, global epidemiological patterns of gastric cancer and Helicobacter pylori, and economic evaluations of genetic screening programs. Methodologically, her work consistently employs decision-analytic modeling, systematic reviews, and cost-effectiveness frameworks across diverse clinical contexts.

Major scientific recognitions include:

• NCI K07 Career Development Award
• American Cancer Society Research Scholar Grant

She currently leads an American Cancer Society-funded project evaluating secondary cancer screening guidelines for childhood cancer survivors.

Her work involves collaborative teams across Harvard-affiliated institutions and national consortia like the Cancer Intervention and Surveillance Modeling Network (CISNET), focusing on translating evidence into clinical practice and policy.